![]() Carmot Therapeutics Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer. | |||
Founding Date | Founding Date 2015 | Founding Date 2014 | Founding Date 2008 |
Type | Type Private | Type Private | Type Subsidiary |
Tags | |||
Locations | Locations Gdańsk, PL HQ Gdańsk, PL | Locations Baltimore, US HQ Lowell, US | Locations Berkeley, US HQ |
Employees | Employees 5 | Employees 9 | Employees 109% decrease |
Funding | |||
Latest funding round | Latest funding round $ 55.5k (about 10 years ago) | Latest funding round $ 20.5m (about 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 55.5k | Total funding raised $ 21m | Total funding raised $ 74.8m |

glyscend is a company that develops a method of treating metabolic diseases.
View company
Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer.
View company